The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia

The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia

Childhood acute lymphoblastic leukemia is a genetically heterogeneous cancer that accounts for 10–15% of T-cell acute lymphoblastic leukemia (T-ALL) cases. The T-ALL event-free survival rate (EFS) is 85%. The evaluation of structural and numerical chromosomal changes is important for a comprehensive...

Full description

Bibliographic Details
Main Authors: Marta Weronika Lato, Anna Przysucha, Sylwia Grosman, Joanna Zawitkowska, Monika Lejman
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
T-ALL
pediatrics
novel therapies
Online Access:https://www.mdpi.com/1422-0067/22/9/4502

Similar Items

Similar Items